Introduction: The anti-angiogenic monoclonal antibody, bevacizumab, is currently used by intravitreal administration as off-label drug to treat age-related macular degeneration or other ophthalmologic diseases. For this purpose, commercial bevacizumab is repackaged in 1mL polypropylene syringes under sterile conditions. However, no complete study on the stability of this hospital-based preparation is available.
Methods: Commercial bevacizumab (25mg/mL; Avastin(®)) was aseptically repackaged in 1mL polypropylene syringes, stored at 4°C, and analyzed within the preparation day (D0), after 30 days (D30) and 90 days (D90). Some syringes were kept for up to 8 months to observe possible instability. Several complementary and stability-indicating analytical methods were used to assess in details the primary, secondary and tertiary structure of the antibody during its conservation: ionic chromatography, size-exclusion chromatography, peptide mapping, 2nd derivative UV and IR spectroscopy, turbidimetry, diffraction laser spectroscopy, thermal denaturation curves, microscopic examination and image analysis.
Results: We clearly demonstrate that the commercial solution of bevacizumab can be safely repackaged in polypropylene syringes and stored up to 3 months at 4°C without alteration of its primary, secondary and tertiary structure. The only difference observed is the contamination of the syringe content by silicone oil microdroplets, which is quite immediate and does not change significantly during the storage in terms of number and size.
Conclusion: Our results support the off-label use of repackaged bevacizumab by intravitreal administration, at least from a pharmaceutical point of view, with a validated stability of 3 months. This stability period is largely enough to practical situations and support current practices, such as in advance or batch preparations, which present major advantages in terms of GMP respect, workload optimization and financial savings.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pharma.2012.03.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Interference of Plasticizers on Plasma Protein Binding Measurements.
AAPS J
December 2024
Pfizer Worldwide Research and Development, Groton, CT, USA.
Accurate measurement of plasma protein binding (PPB) is of critical importance in drug discovery. Methodologies for PPB measurement continue to evolve to address the challenges of highly bound compounds. In order to generate high quality PPB data, it is crucial to not only apply state-of-the-art methods and highly sensitive and selective detectors, but also use high-quality plasma.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the stability and safety of faricimab, an anti-VEGF biologic, when compounded into two types of polypropylene syringes and stored for 28 days.
- No significant differences in binding affinity for VEGF and Ang-2 were observed between the syringe types, and the compound maintained its chemical and physical stability, sterility, and lack of bacterial endotoxins.
- These results support the safe off-label use of faricimab, potentially reducing costs while ensuring patient safety in clinical practice.
Melt-blown polypropylene nonwoven as an efficient and eco-economic sorbent for pipette tip micro-solid phase extraction for the determination of tyrosine kinase inhibitors.
Anal Chim Acta
November 2024
Henan Key Laboratory of Nanomedicine for Targeting Diagnosis and Treatment, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China. Electronic address:
Article Synopsis
- Need for Improved TKI Detection
- : Traditional methods for detecting tyrosine kinase inhibitors (TKIs) in biological fluids are complex, resource-intensive, and not sensitive enough, creating a demand for more efficient and eco-friendly alternatives.
- Innovative Extraction Method
- : This study introduces a new extraction technique using melt-blown polypropylene nonwoven (MBPP) material, which shows high adsorption capacity and allows for quick extraction from samples in just 3 minutes using a simple device setup.
- Promising Results
- : The new method demonstrated excellent extraction efficiency, accuracy, and sensitivity when validated with liquid chromatography-tandem mass spectrometry (LC-MS/MS), indicating it’s a viable solution for improved TKI detection.*
Study of leachable compounds in hospital pharmacy-compounded prefilled syringes, infusion bags and vials.
J Pharm Sci
November 2024
Pharmacy Department, Lausanne University Hospital, Switzerland; Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Switzerland; School of Pharmaceutical Sciences, University of Geneva, CMU-Rue Michel Servet 1, 1211, Geneva 4, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Switzerland. Electronic address:
Hospital pharmacy compoundings are crucial for maintaining patient care. They are time- and cost-effective in hospital pharmacy settings because they prevent waste, preparation errors, dosage errors, microbial contamination and breakage due to handling. Unfortunately, the drawbacks of hospital pharmacy compounding include the selection of inappropriate medical devices (MDs) for long-term storage, which could directly impact patients.
View Article and Find Full Text PDFLong-term stability of esketamine in polypropylene syringes at 5 ± 3°C.
Eur J Hosp Pharm
December 2024
Department of Medical Laboratory, CHU UCL Namur, Yvoir, Belgium.
Objective: Esketamine (Vesierra) is a molecule, used alone or in combination, to induce and maintain general anaesthesia and to relieve pain in emergency medicine. The aim of this study is to evaluate the long-term physicochemical stability of a 1 mg/mL solution of esketamine diluted in 0.9% sodium chloride (NaCl) and stored in polypropylene syringes at 5±3°C during 65 days (64+1 day at 22±3°C) and 72 hours at 22±3°C (room temperature), in order to centralise preparation under aseptic conditions in hospital pharmacy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!